Opening of the Site: HIB-vaccine for children from 3 to 6 months

Recruitment for a clinical trial of a new Russian HIB vaccine for children from 3 to 6 months has begun. The comparison drug is Pentaxime, the placebo group is not assumed. All examination and supervision of a pediatrician is free of charge.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen